World's Best Scientists 2026 revealed!
R. Sharon Chinthrajah

R. Sharon Chinthrajah

D-Index & Metrics

Immunology

D-Index
49
Citations
8936
World Ranking
4343
National Ranking
1974

R. Sharon Chinthrajah publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where R. Sharon Chinthrajah sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 243 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

R. Sharon Chinthrajah D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where R. Sharon Chinthrajah sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

R. Sharon Chinthrajah is affiliated with Stanford University in the United States. Their primary field of study is Medicine, with a focus on Immunology and Allergy, Physiology, Infectious Diseases, Immunology, and Surgery. Their research spans multiple subfields with a strong emphasis on immunological responses and allergic conditions.

Their recent publications cover a range of topics related to immunology, infectious diseases, and allergic reactions. Notable papers include:

  • Systems vaccinology of the BNT162b2 mRNA vaccine in humans, 2021, published in Nature
  • Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination, 2022, published in Cell
  • New-onset IgG autoantibodies in hospitalized patients with COVID-19, 2021, published in Nature Communications
  • Food allergy across the globe, 2021, published in Journal of Allergy and Clinical Immunology
  • Omalizumab for the Treatment of Multiple Food Allergies, 2024, published in New England Journal of Medicine

Their frequent co-authors include Kari C. Nadeau, Sayantani Sindher, Andrew Long, Shu Cao, and Monali Manohar. These collaborations reflect an extensive network within the allergy and immunology research community.

R. Sharon Chinthrajah's work is regularly featured in several prominent publication venues, showing the scope and influence of their research. These venues include:

  • Journal of Allergy and Clinical Immunology
  • Allergy
  • The Journal of Allergy and Clinical Immunology In Practice
  • Annals of Allergy Asthma & Immunology
  • Frontiers in Allergy

The main research topics addressed by Chinthrajah include:

  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Eosinophilic Esophagitis
  • Contact Dermatitis and Allergies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research

The focus on food allergies, asthma, and respiratory conditions represents a significant portion of their publication record. Their engagement in SARS-CoV-2 and COVID-19 research also shows responsiveness to emerging global health challenges within their wider immunological expertise.

Best Publications

  • Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

    Unknown

  • Systems vaccinology of the BNT162b2 mRNA vaccine in humans.

    Prabhu S. Arunachalam;Madeleine K. D. Scott;Thomas Hagan;Thomas Hagan;Chunfeng Li

  • New-onset IgG autoantibodies in hospitalized patients with COVID-19.

    Sarah Esther Chang;Allan Feng;Wenzhao Meng;Sokratis A Apostolidis

  • Food allergy across the globe.

    Unknown

  • Molecular and cellular mechanisms of food allergy and food tolerance

    R. Sharon Chinthrajah;Joseph D. Hernandez;Scott D. Boyd;Stephen J. Galli

  • Omalizumab facilitates rapid oral desensitization for peanut allergy

    Andrew J. MacGinnitie;Rima Rachid;Hana Gragg;Sara V. Little

  • Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

    R Sharon Chinthrajah;Natasha Purington;Sandra Andorf;Andrew Long

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial

    David M. Fleischer;Matthew Greenhawt;Gordon Sussman;Philippe Bégin

  • Omalizumab for the Treatment of Multiple Food Allergies.

    Unknown

  • Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial

    Sandra Andorf;Natasha Purington;Whitney M Block;Andrew J Long

  • Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.

    Sharon Chinthrajah;Shu Cao;Cherie Liu;Shu-Chen Lyu

  • Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets

    John F. Ryan;Rachel Hovde;Jacob Glanville;Shu-Chen Lyu

  • Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy

    Ramona A. Hoh;Shilpa A. Joshi;Ji-Yeun Lee;Brock A. Martin

  • Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.

    Christopher Michael Warren;Christopher Michael Warren;Theo Thomas Snow;Alexandra S. Lee;Mihir Mukesh Shah

  • A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

    Sandra Andorf;Natasha Purington;Divya Kumar;Andrew Long

  • COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper.

    Oliver Pfaar;L Klimek;M Jutel;C A Akdis

  • Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives.

    Vanitha Sampath;Grace Rabinowitz;Mihir Shah;Surabhi Jain

  • Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.

    Mindy Tsai;Kaori Mukai;R. Sharon Chinthrajah;Kari C. Nadeau

  • Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis

    Unknown

  • Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.

    Unknown

  • Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis

    Kaori Mukai;Nicolas Gaudenzio;Sheena Gupta;Nora Vivanco;Nora Vivanco

  • Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children

    Sandra Andorf;Magnus P. Borres;Magnus P. Borres;Whitney Block;Dana Tupa

  • ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).

    Jean Bousquet;Marek Jutel;Cezmi A. Akdis;Ludger Klimek

  • Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

    David M. Fleischer;Wayne G. Shreffler;Dianne E. Campbell;Dianne E. Campbell;Todd D. Green;Todd D. Green

  • Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives

    Vanitha Sampath;Grace Rabinowitz;Mihir Shah;Surabhi Jain

Frequent Co-Authors

Kari C. Nadeau
Kari C. Nadeau Harvard University
Stephen J. Galli
Stephen J. Galli Stanford University
Scott D. Boyd
Scott D. Boyd Stanford University
Mindy Tsai
Mindy Tsai Stanford University
Holden T. Maecker
Holden T. Maecker Stanford University
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Jacqueline A. Pongracic
Jacqueline A. Pongracic Lurie Children's Hospital
Robert Tibshirani
Robert Tibshirani Stanford University
Amal Assa'ad
Amal Assa'ad Cincinnati Children's Hospital Medical Center
Benjamin A. Pinsky
Benjamin A. Pinsky Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related fields such as nursing can broaden career options. Many students pursue specialized nurse practitioner tracks that complement immunology knowledge. Programs known as the easiest nurse practitioner degree programs provide accessible pathways for students balancing work and study commitments.

Mental health nursing is another growing area. The online best pmhnp programs focus on psychiatric mental health nurse practitioner education, often offering strong clinical placements that are crucial for hands-on experience.

Cost is a key consideration when selecting a program. Many students seek the affordable pmhnp programs to lessen financial burden while maintaining the quality of education and clinical training.

Advanced degrees, such as a Doctorate in Nursing Practice (DNP), can significantly impact earning potential. Understanding the doctorate in nursing salary helps prospective students determine the return on investment of their education.

Best Scientists Citing R. Sharon Chinthrajah

Trending Scientists

Recently Published Articles